Sonorous Neurovascular announced today that it received FDA 510(k) clearance for its BosCATH next-generation neurovascular ...
Sonorous Neurovascular, a pioneering medical device company focused on innovative solutions for cerebral venous diseases and neurovascular interventions, today announced that it has received 510(k) ...
Sonorous Neurovascular, a developer of solutions for cerebral venous diseases and neurovascular interventions, announced that ...
LAKE FOREST, Calif., March 27, 2026 /PRNewswire/ -- Sonorous NV, Inc. today announced management changes pursuant to which Paul Brooke, a current Board member, has become Chairman of the Board. In ...
Sonorous Neurovascular, a pioneering medical device company focused on innovative solutions for cerebral venous diseases and neurovascular interventions, today announced that it has received 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results